scholarly article | Q13442814 |
MDMA | Q69488 |
P50 | author | Dimitri Gerostamoulos | Q57556375 |
Luke N. Rodda | Q39906791 | ||
P2093 | author name string | Elizabeth Jenkins | |
Matthew Di Rago | |||
Mark Chu | |||
Alex Kotsos | |||
P2860 | cites work | Development of an LC-MS/MS method for the simultaneous determination of 25 benzodiazepines and zolpidem in oral fluid and its application to authentic samples from regular drug users. | Q50731804 |
Drugs in oral fluid in randomly selected drivers. | Q51744586 | ||
Determination of pharmaceutical and illicit drugs in oral fluid by ultra-high performance liquid chromatography-tandem mass spectrometry. | Q53878293 | ||
Detection of drugs of abuse in simultaneously collected oral fluid, urine and blood from Norwegian drug drivers. | Q54050683 | ||
The incidence of drugs of impairment in oral fluid from random roadside testing | Q57838161 | ||
An assessment of the stability of MDMA, methamphetamine and THC in oral fluid | Q57986566 | ||
Driving under the influence of drugs -- evaluation of analytical data of drugs in oral fluid, serum and urine, and correlation with impairment symptoms | Q30992865 | ||
Dose related risk of motor vehicle crashes after cannabis use. | Q33975160 | ||
Oral fluid testing for drugs of abuse | Q35190524 | ||
Review: Pharmacokinetics of illicit drugs in oral fluid | Q36156166 | ||
Oral fluid testing for driving under the influence of drugs: history, recent progress and remaining challenges. | Q36156170 | ||
Validation of new methods | Q36510010 | ||
Associations between driving under the influence of alcohol or drugs, speeding and seatbelt use among fatally injured car drivers in Norway | Q41336151 | ||
Identification and quantification of 30 antipsychotics in blood using LC-MS/MS. | Q42962996 | ||
The Victorian legislative framework for the random testing drivers at the roadside for the presence of illicit drugs: an evaluation of the characteristics of drivers detected from 2004 to 2006. | Q44171496 | ||
Quantitation of cocaine and its major metabolites in human saliva using gas chromatography-positive chemical ionization-mass spectrometry (GC-PCI-MS). | Q44543237 | ||
Driving under the influence among frequent ecstasy consumers in Australia: trends over time and the role of risk perceptions | Q44578997 | ||
The involvement of drugs in drivers of motor vehicles killed in Australian road traffic crashes. | Q44672030 | ||
Recovery of spiked Δ9-tetrahydrocannabinol in oral fluid from polypropylene containers | Q44869076 | ||
Validated toxicological determination of 30 drugs of abuse as optimized derivatives in oral fluid by long column fast gas chromatography/electron impact mass spectrometry | Q46418608 | ||
Liquid chromatography-electrospray ionisation mass spectrometry for the determination of nine selected benzodiazepines in human plasma and oral fluid | Q46696363 | ||
Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. | Q47636202 | ||
Cognition and motor control as a function of Delta9-THC concentration in serum and oral fluid: limits of impairment | Q48932960 | ||
The combined effects of alcohol and cannabis on driving: Impact on crash risk. | Q50048296 | ||
Profile of a drunk driver and risk factors for drunk driving. Findings in roadside testing in the province of Uusimaa in Finland 1990-2008. | Q50054910 | ||
P4510 | describes a project that uses | liquid chromatography–mass spectrometry | Q873864 |
liquid chromatography-tandem mass spectrometry | Q117788892 | ||
P433 | issue | 14 | |
P407 | language of work or name | English | Q1860 |
P1104 | number of pages | 13 | |
P304 | page(s) | 3737-3749 | |
P577 | publication date | 2016-03-18 | |
P1433 | published in | Analytical and Bioanalytical Chemistry | Q2845280 |
P1476 | title | Ultra-rapid targeted analysis of 40 drugs of abuse in oral fluid by LC-MS/MS using carbon-13 isotopes of methamphetamine and MDMA to reduce detector saturation | |
P478 | volume | 408 |
Q48167533 | A simple validated multi-analyte method for detecting drugs in oral fluid by ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS). |
Q90295566 | A validated workflow for drug detection in oral fluid by non-targeted liquid chromatography-tandem mass spectrometry |
Q38957777 | Increasing the linear dynamic range in LC-MS: is it valid to use a less abundant isotopologue? |
Q64230197 | Opioid Use in Pregnant Women and Neonatal Abstinence Syndrome-A Review of the Literature |